← Leaderboards
Jean Kyou Lim
Icahn School Of Medicine At Mount Sinai
$13,225,849
Attributed
$14,949,333
Total exposure
16
Grants
14
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.5M · FY2011–25$5M$3.8M$2.5M$1.3M$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$14,949,333 · 16
By mechanism
R01$10,004,188 · 5
R21$3,700,770 · 8
R37$805,375 · 1
K22$270,000 · 1
R03$169,000 · 1
Top collaborators
- Shuibing Chen3 shared
- Benhur Lee3 shared
- Robert E Schwartz3 shared
- Jeffrey R Johnson2 shared
Most similar at Icahn School Of Medicine At Mount Sinai
Same institution · by research overlap
- Susana Bardina$109,020
- William Paul Duprex$23,556,651
Others in their field
Top investigators on “Infection”
- Wafaa M. El-Sadr · Columbia University Health Sciences$965,939,185
- Lawrence Corey · Fred Hutchinson Cancer Center$789,608,171
- Judith S. Currier · University Of California Los Angeles$511,038,212
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$463,711,983
- Richard Marlink · Elizabeth Glaser Pediatric Aids Fdn$457,210,249
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$415,229,497
Research focus
InfectionCellsPathogenesisVirusIn VivoPredispositionViral PathogenesisDisease OutbreaksVirus ReplicationMediatingMacrophageCulicidaeFlavivirusWest Nile VirusChemokineVirus DiseasesZika VirusEventAntibodiesBaseImmune ResponseUnited StatesVaccinesTissues
Grant awards (38)
Deciphering the Role of Chemokine Receptor CCR5 in Maternal Flavivirus Infections$3,021,038
R01 · FY2025 · AI · contact PI
Understanding the Tropism and Pathogenesis of Pararubulaviruses$805,375
R37 · FY2025 · AI
Identification of the initial cells infected by West Nile virus ex vivo and in vivo$540,265
R01 · FY2025 · AI · contact PI
Developing Novel Tools to Study Chemokine Receptor Ccr5 Expression and Function in Mice$84,500
R03 · FY2025 · AI · contact PI
Identification of the initial cells infected by West Nile virus ex vivo and in vivo$540,265
R01 · FY2024 · AI · contact PI
Enhanced susceptibility to Zika virus during pregnancy: a role for maternal dengue antibodies$421,878
R01 · FY2024 · AI · contact PI
Developing Novel Tools to Study Chemokine Receptor Ccr5 Expression and Function in Mice$84,500
R03 · FY2024 · AI · contact PI
Identification of the initial cells infected by West Nile virus ex vivo and in vivo$540,265
R01 · FY2023 · AI · contact PI
Decode the Impact of SARS-CoV-2 on Human Pancreas$422,571
R01 · FY2023 · DK
Enhanced susceptibility to Zika virus during pregnancy: a role for maternal dengue antibodies$421,878
R01 · FY2023 · AI · contact PI
Identification of the initial cells infected by West Nile virus ex vivo and in vivo$557,515
R01 · FY2022 · AI · contact PI
Decode the Impact of SARS-CoV-2 on Human Pancreas$422,571
R01 · FY2022 · DK
Enhanced susceptibility to Zika virus during pregnancy: a role for maternal dengue antibodies$421,878
R01 · FY2022 · AI · contact PI
Multi-dimensional comparison of differentially pathogenic coronaviruses (CoV) in human lung tissue$211,250
R21 · FY2022 · AI · contact PI
Decode the Impact of SARS-CoV-2 on Human Pancreas$440,068
R01 · FY2021 · DK
Enhanced susceptibility to Zika virus during pregnancy: a role for maternal dengue antibodies$421,878
R01 · FY2021 · AI · contact PI
Multi-dimensional comparison of differentially pathogenic coronaviruses (CoV) in human lung tissue$253,750
R21 · FY2021 · AI · contact PI
Human Parainfluenza Virus 3 Infection in a Novel Human Lung Tissue Model$210,302
R21 · FY2021 · AI · contact PI
Enhanced susceptibility to Zika virus during pregnancy: a role for maternal dengue antibodies$421,878
R01 · FY2020 · AI · contact PI
Human Parainfluenza Virus 3 Infection in a Novel Human Lung Tissue Model$252,677
R21 · FY2020 · AI · contact PI
Enhancement of Zika virus pathogenesis in neonates through dengue-specific maternal antibodies$211,267
R21 · FY2020 · AI · contact PI
Genetic Susceptibility of Antibody-dependent Enhancement of Flaviviruses$211,252
R21 · FY2020 · AI · contact PI
Enhancement of Zika virus pathogenesis in neonates through dengue-specific maternal antibodies$253,642
R21 · FY2019 · AI · contact PI
Genetic Susceptibility of Antibody-dependent Enhancement of Flaviviruses$253,627
R21 · FY2019 · AI · contact PI
Impact of pre-existing dengue virus immunity on Zika virus infection of placenta$211,268
R21 · FY2019 · AI · contact PI
Impact of pre-existing dengue virus immunity on Zika virus infection of placenta$253,643
R21 · FY2018 · AI · contact PI
Human Ex Vivo Models of Zika Virus Infection$210,618
R21 · FY2018 · AI · contact PI
Determining West Nile virus antibody-dependent enhancement of Zika virus$210,618
R21 · FY2018 · AI · contact PI
Chemokine regulation of myeloid cell populations during West Nile virus infection$352,560
R01 · FY2017 · AI · contact PI
Determining West Nile virus antibody-dependent enhancement of Zika virus$252,993
R21 · FY2017 · AI · contact PI
Human Ex Vivo Models of Zika Virus Infection$252,993
R21 · FY2017 · AI · contact PI
Chemokine regulation of myeloid cell populations during West Nile virus infection$352,560
R01 · FY2016 · AI · contact PI
Chemokine regulation of myeloid cell populations during West Nile virus infection$352,560
R01 · FY2015 · AI · contact PI
Chemokine regulation of myeloid cell populations during West Nile virus infection$352,560
R01 · FY2014 · AI · contact PI
A novel ex vivo model of West Nile virus infection in human lymphoid tissue$211,875
R21 · FY2014 · AI · contact PI
A novel ex vivo model of West Nile virus infection in human lymphoid tissue$238,995
R21 · FY2013 · AI · contact PI
Mechanisms of CCR2-mediated neuroprotection in West Nile Virus infection$108,000
K22 · FY2012 · AI · contact PI
Mechanisms of CCR2-mediated neuroprotection in West Nile Virus infection$162,000
K22 · FY2011 · AI · contact PI